Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

SpringWorks Therapeutics, Inc.

SWTX•NASDAQ
Healthcare
Biotechnology
$46.99
$0.00(0.00%)
U.S. Market is Open • 12:27

SpringWorks Therapeutics, Inc. (SWTX) Stock Overview

Explore SpringWorks Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio-16.44
EPS (TTM)$-3.41
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$44.35

SWTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SpringWorks Therapeutics, Inc. (SWTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $44.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.44 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.49%
6-Month Change
25.31%
Year-to-Date (YTD) Change
30.24%
1-Year Change
30.85%
3-Year Change
67.46%
5-Year Change
10.23%
All-Time (Max) Change
107.64%

Contact Information

https://www.springworkstx.com
203 883 9490
100 Washington Boulevard, Stamford, CT, 06902

Company Facts

3,680 Employees
IPO DateSep 13, 2019
CountryUS

Frequently Asked Questions